Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data.

BMC Genomics · 2004 · PMC544889 · PMID 15598354

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

A strength of the inter-study validated signature is the capability of recruiting genes which may not be significant in one study due to limiting sample size or artifacts of the experiments.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.